Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of the Liver
2022-04-01
|
| Series: | Clinical and Molecular Hepatology |
| Subjects: | |
| Online Access: | http://e-cmh.org/upload/pdf/cmh-2022-0040.pdf |
| _version_ | 1811329833477603328 |
|---|---|
| author | Saori Takamura Yuichi Teraki Eri Katayama Takumi Kawaguchi Machiko Kawaguchi Dan Nakano Tsubasa Tsutsumi Sumiko Nagoshi Takekuni Nakama Takuji Torimura |
| author_facet | Saori Takamura Yuichi Teraki Eri Katayama Takumi Kawaguchi Machiko Kawaguchi Dan Nakano Tsubasa Tsutsumi Sumiko Nagoshi Takekuni Nakama Takuji Torimura |
| author_sort | Saori Takamura |
| collection | DOAJ |
| first_indexed | 2024-04-13T15:50:54Z |
| format | Article |
| id | doaj.art-695464608e6d418690040ea52c932774 |
| institution | Directory Open Access Journal |
| issn | 2287-2728 2287-285X |
| language | English |
| last_indexed | 2024-04-13T15:50:54Z |
| publishDate | 2022-04-01 |
| publisher | Korean Association for the Study of the Liver |
| record_format | Article |
| series | Clinical and Molecular Hepatology |
| spelling | doaj.art-695464608e6d418690040ea52c9327742022-12-22T02:40:51ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2022-04-0128226927210.3350/cmh.2022.00401663Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphsSaori Takamura0Yuichi Teraki1Eri Katayama2Takumi Kawaguchi3Machiko Kawaguchi4Dan Nakano5Tsubasa Tsutsumi6Sumiko Nagoshi7Takekuni Nakama8Takuji Torimura9 Department of Dermatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan Department of Dermatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan Department of Dermatology, Kurume University School of Medicine, Kurume, Japan Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan Department of Dermatology, Kurume University School of Medicine, Kurume, Japan Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japanhttp://e-cmh.org/upload/pdf/cmh-2022-0040.pdfnon-alcoholic fatty liver diseasemetabolic diseasespsoriasisinterleukin-17liver fibrosis |
| spellingShingle | Saori Takamura Yuichi Teraki Eri Katayama Takumi Kawaguchi Machiko Kawaguchi Dan Nakano Tsubasa Tsutsumi Sumiko Nagoshi Takekuni Nakama Takuji Torimura Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs Clinical and Molecular Hepatology non-alcoholic fatty liver disease metabolic diseases psoriasis interleukin-17 liver fibrosis |
| title | Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs |
| title_full | Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs |
| title_fullStr | Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs |
| title_full_unstemmed | Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs |
| title_short | Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs |
| title_sort | effects of interleukin 17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction associated fatty liver disease directed acyclic graphs |
| topic | non-alcoholic fatty liver disease metabolic diseases psoriasis interleukin-17 liver fibrosis |
| url | http://e-cmh.org/upload/pdf/cmh-2022-0040.pdf |
| work_keys_str_mv | AT saoritakamura effectsofinterleukin17inhibitorsonhepaticfibrosisindexinpatientswithpsoriasisandmetabolicdysfunctionassociatedfattyliverdiseasedirectedacyclicgraphs AT yuichiteraki effectsofinterleukin17inhibitorsonhepaticfibrosisindexinpatientswithpsoriasisandmetabolicdysfunctionassociatedfattyliverdiseasedirectedacyclicgraphs AT erikatayama effectsofinterleukin17inhibitorsonhepaticfibrosisindexinpatientswithpsoriasisandmetabolicdysfunctionassociatedfattyliverdiseasedirectedacyclicgraphs AT takumikawaguchi effectsofinterleukin17inhibitorsonhepaticfibrosisindexinpatientswithpsoriasisandmetabolicdysfunctionassociatedfattyliverdiseasedirectedacyclicgraphs AT machikokawaguchi effectsofinterleukin17inhibitorsonhepaticfibrosisindexinpatientswithpsoriasisandmetabolicdysfunctionassociatedfattyliverdiseasedirectedacyclicgraphs AT dannakano effectsofinterleukin17inhibitorsonhepaticfibrosisindexinpatientswithpsoriasisandmetabolicdysfunctionassociatedfattyliverdiseasedirectedacyclicgraphs AT tsubasatsutsumi effectsofinterleukin17inhibitorsonhepaticfibrosisindexinpatientswithpsoriasisandmetabolicdysfunctionassociatedfattyliverdiseasedirectedacyclicgraphs AT sumikonagoshi effectsofinterleukin17inhibitorsonhepaticfibrosisindexinpatientswithpsoriasisandmetabolicdysfunctionassociatedfattyliverdiseasedirectedacyclicgraphs AT takekuninakama effectsofinterleukin17inhibitorsonhepaticfibrosisindexinpatientswithpsoriasisandmetabolicdysfunctionassociatedfattyliverdiseasedirectedacyclicgraphs AT takujitorimura effectsofinterleukin17inhibitorsonhepaticfibrosisindexinpatientswithpsoriasisandmetabolicdysfunctionassociatedfattyliverdiseasedirectedacyclicgraphs |